![[dr. bob]](/dr-bob-sm.gif)
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.orgShown: posts 1 to 4 of 4. This is the beginning of the thread.
Posted by bearfan on June 2, 2010, at 17:25:13
From what I heard, it has impressive HAM-D and HAM-A scores and excellent tolerability with sexual side effects and weight gain no different from placebo. Anyone have any experience (ie clinical trials), or inside information about it?
Posted by Phillipa on June 2, 2010, at 17:46:31
In reply to FDA Accepts NDA from new Dual Acting Antidepressan, posted by bearfan on June 2, 2010, at 17:25:13
Are you saying the US Fda is accepting a new is it for clinical trial? Phillipa
Posted by SLS on June 3, 2010, at 6:27:12
In reply to FDA Accepts NDA from new Dual Acting Antidepressan, posted by bearfan on June 2, 2010, at 17:25:13
> From what I heard, it has impressive HAM-D and HAM-A scores and excellent tolerability with sexual side effects and weight gain no different from placebo. Anyone have any experience (ie clinical trials), or inside information about it?
I hope this drug has better luck with the FDA than did gepirone. Gepirone, a drug with similar properties to vilazodone, was rejected twice.
- Scott
Posted by desolationrower on June 3, 2010, at 15:38:22
In reply to FDA Accepts NDA from new Dual Acting Antidepressan, posted by bearfan on June 2, 2010, at 17:25:13
christ we need structural modifiers/nanobots/etc
think, one COULD contruct a info processor just of a single signal type
such as the compute-er that you are reading this on
evolution only happened to favor multiptle signals
it is possible that monoamines and a few things like benzos are the best you can do on gross signal levels. MAOIS are about it.
-d/r
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.